AC Immune (ACIU) Operating Leases (2017 - 2026)

AC Immune (ACIU) has 9 years of Operating Leases data on file, last reported at $4.4 billion in Q1 2026.

• On a quarterly basis, Operating Leases rose 96334.89% year-over-year to $4.4 billion in Q1 2026; TTM through Mar 2026 was $4.4 billion, a 96334.89% increase from a year earlier, with the FY2025 full-year figure at $4.4 billion, up 88465.92% from the prior year.
• Operating Leases for Q1 2026 stood at $4.4 billion, down from $4.6 billion in the prior quarter.
• Over the last five years, Operating Leases for ACIU reached as high as $4.6 billion in Q4 2025 and fell as low as $2.0 million in Q3 2022.
• Historically, Operating Leases has averaged $987.5 million across 5 years, with a median of $4.5 million in 2025.
• Across the five-year window, Operating Leases slumped 99.91% in 2022 and surged 136079.34% in 2023, its largest moves.
• Year by year, Operating Leases stood at $2.3 million in 2022, then surged by 136079.34% to $3.2 billion in 2023, then tumbled by 99.84% to $5.0 million in 2024, then surged by 91773.3% to $4.6 billion in 2025, then retreated by 3.75% to $4.4 billion in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $4.4 billion in Q1 2026, $4.6 billion in Q4 2025, and $4.5 million in Q3 2025.